SYNOPSIS

At this Summit, sessions dove deep into the changing paradigm of cancer screening and surveillance, the state of rare disease drug discovery, and precision medicine in adults beyond oncology. The continuation of the “case study” format enabled participants to share successes in multi-stakeholder collaboration. Finally, individuals shared powerful stories of their personal journey with precision medicine as patients and advocates. 

Three impactful themes emerged that differentiated the discussion from previous meetings:

1. While diagnostic testing provides an unprecedented number of useful applications, the frameworks for understanding the benefits and outcomes across the care continuum are insufficient.

2. The technology for precision health has largely arrived, but the patient experience has not.

3. Precision health will be more than genomic; it will be multi-omic.

Download the whitepaper to read more.